id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1995-P-0415-0002,FDA,FDA-1995-P-0415,Citizen Petition from Schering Corporation,Other,Citizen Petition,2017-02-02T05:00:00Z,2017,2,2017-02-02T05:00:00Z,,2017-02-03T02:04:43Z,,0,0,09000064805a646a
FDA-1995-P-0415-0005,FDA,FDA-1995-P-0415,Interim Response Letter from FDA CDER to Schering-Plough Research Institute,Other,Letter(s),2017-02-02T05:00:00Z,2017,2,2017-02-02T05:00:00Z,,2017-02-02T19:14:43Z,,0,0,09000064805a646f
FDA-1995-P-0415-0004,FDA,FDA-1995-P-0415,Response from Schering-Plough Research Institute to FDA DDM,Other,Response(s),2017-02-02T05:00:00Z,2017,2,2017-02-02T05:00:00Z,,2017-02-02T19:12:28Z,,0,0,09000064805a646d
FDA-1995-P-0415-0006,FDA,FDA-1995-P-0415,Petition Denial Letter from FDA CDER to Schering-Plough Research Institute,Other,Denial of Petition,2017-02-02T05:00:00Z,2017,2,2017-02-02T05:00:00Z,,2017-02-02T19:17:40Z,,0,0,09000064805a6470